| KASL clinical practice guidelines: management of nonalcoholic fatty liver disease SH Kang, HW Lee, JJ Yoo, Y Cho, SU Kim, TH Lee, BK Jang, SG Kim, ... Clinical and molecular hepatology 27 (3), 363, 2021 | 226 | 2021 |
| Identification of a quadruple mutation that confers tenofovir resistance in chronic hepatitis B patients ES Park, AR Lee, DH Kim, JH Lee, JJ Yoo, SH Ahn, H Sim, S Park, ... Journal of Hepatology 70 (6), 1093-1102, 2019 | 141 | 2019 |
| Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy SH Kang, YB Lee, JH Lee, JY Nam, Y Chang, H Cho, JJ Yoo, YY Cho, ... Alimentary pharmacology & therapeutics 46 (9), 845-855, 2017 | 135 | 2017 |
| Antiplatelet therapy and the risk of hepatocellular carcinoma in chronic hepatitis B patients on antiviral treatment M Lee, GE Chung, JH Lee, S Oh, JY Nam, Y Chang, H Cho, H Ahn, ... Hepatology 66 (5), 1556-1569, 2017 | 115 | 2017 |
| Estimation of renal function in patients with liver cirrhosis: Impact of muscle mass and sex JJ Yoo, SG Kim, YS Kim, B Lee, MH Lee, SW Jeong, JY Jang, SH Lee, ... Journal of hepatology 70 (5), 847-854, 2019 | 98 | 2019 |
| CLIF‐SOFA scoring system accurately predicts short‐term mortality in acutely decompensated patients with alcoholic cirrhosis: a retrospective analysis M Lee, JH Lee, S Oh, Y Jang, W Lee, HJ Lee, J Yoo, WM Choi, YY Cho, ... Liver International 35 (1), 46-57, 2015 | 94 | 2015 |
| Recent research trends and updates on nonalcoholic fatty liver disease JJ Yoo, W Kim, MY Kim, DW Jun, SG Kim, JE Yeon, JW Lee, YK Cho, ... Clinical and molecular hepatology 25 (1), 1, 2018 | 89 | 2018 |
| Effects of virologic response to treatment on short-and long-term outcomes of patients with chronic hepatitis B virus infection and decompensated cirrhosis JW Jang, JY Choi, YS Kim, JJ Yoo, HY Woo, SK Choi, CH Jun, CH Lee, ... Clinical gastroenterology and hepatology 16 (12), 1954-1963. e3, 2018 | 72 | 2018 |
| Does 18F-FDG Positron Emission Tomography-Computed Tomography Have a Role in Initial Staging of Hepatocellular Carcinoma? Y Cho, DH Lee, YB Lee, M Lee, J Yoo, W Choi, YY Cho, JC Paeng, ... PLoS One 9 (8), e105679, 2014 | 59 | 2014 |
| Fucoidan protects hepatocytes from apoptosis and inhibits invasion of hepatocellular carcinoma by up-regulating p42/44 MAPK-dependent NDRG-1/CAP43 Y Cho, JH Yoon, J Yoo, M Lee, DH Lee, EJ Cho, JH Lee, SJ Yu, YJ Kim, ... Acta Pharmaceutica Sinica B 5 (6), 544-553, 2015 | 46 | 2015 |
| Prior exposure to lamivudine increases entecavir resistance risk in chronic hepatitis B Patients without detectable lamivudine resistance JH Lee, Y Cho, DH Lee, M Lee, J Yoo, W Choi, YY Cho, YB Lee, SJ Yu, ... Antimicrobial agents and chemotherapy 58 (3), 1730-1737, 2014 | 44 | 2014 |
| A population‐based study of pyogenic liver abscess in Korea: incidence, mortality and temporal trends during 2007‐2017 JJ Yoo, TK Lee, DS Kyoung, MA Park, SG Kim, YS Kim Liver International 41 (11), 2747-2758, 2021 | 43 | 2021 |
| Efficacy of entecavir-tenofovir combination therapy for chronic hepatitis B patients with multidrug-resistant strains YB Lee, JH Lee, DH Lee, H Cho, H Ahn, WM Choi, YY Cho, M Lee, ... Antimicrobial Agents and Chemotherapy 58 (11), 6710-6716, 2014 | 43 | 2014 |
| Hexokinase-II inhibition synergistically augments the anti-tumor efficacy of sorafenib in hepatocellular carcinoma JJ Yoo, SJ Yu, J Na, K Kim, YY Cho, YB Lee, EJ Cho, JH Lee, YJ Kim, ... International journal of molecular sciences 20 (6), 1292, 2019 | 42 | 2019 |
| Urinary microbiome characteristics in female patients with acute uncomplicated cystitis and recurrent cystitis JJ Yoo, HB Shin, JS Song, M Kim, J Yun, Z Kim, YM Lee, SW Lee, KW Lee, ... Journal of clinical medicine 10 (5), 1097, 2021 | 41 | 2021 |
| Association between lipid profiles and the incidence of hepatocellular carcinoma: a nationwide population-based study Y Cho, EJ Cho, JJ Yoo, Y Chang, GE Chung, SM Jeong, SH Park, K Han, ... Cancers 13 (7), 1599, 2021 | 40 | 2021 |
| Reduced risk of hepatocellular carcinoma by achieving a subcirrhotic liver stiffness through antiviral agents in hepatitis B virus‐related advanced fibrosis or cirrhosis BS Kim, YS Seo, YS Kim, CH Lee, HA Lee, SH Um, JJ Yoo, SG Kim, ... Journal of Gastroenterology and Hepatology 33 (2), 503-510, 2018 | 40 | 2018 |
| Risk of fatty liver after long-term use of tamoxifen in patients with breast cancer JJ Yoo, YS Lim, MS Kim, B Lee, BY Kim, Z Kim, JE Lee, MH Lee, SG Kim, ... PloS one 15 (7), e0236506, 2020 | 39 | 2020 |
| Combined therapy of transarterial chemoembolization and stereotactic body radiation therapy versus transarterial chemoembolization for≤ 5cm hepatocellular carcinoma … BG Jun, SG Kim, YD Kim, GJ Cheon, KH Han, JJ Yoo, YS Kim, SW Jeong, ... PLoS One 13 (10), e0206381, 2018 | 38 | 2018 |
| Targeted proteomics predicts a sustained complete-response after transarterial chemoembolization and clinical outcomes in patients with hepatocellular carcinoma: a prospective … SJ Yu, H Kim, H Min, A Sohn, YY Cho, JJ Yoo, DH Lee, EJ Cho, JH Lee, ... Journal of proteome research 16 (3), 1239-1248, 2017 | 33 | 2017 |